These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38353701)

  • 1. A Viral Protein 4-Based Trivalent Nanoparticle Vaccine Elicited High and Broad Immune Responses and Protective Immunity against the Predominant Rotaviruses.
    Xia M; Huang P; Vago F; Kawagishi T; Ding S; Greenberg HB; Jiang W; Tan M
    ACS Nano; 2024 Feb; 18(8):6673-6689. PubMed ID: 38353701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Cross P Type Immune Response.
    Xia M; Huang P; Tan M
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 36015223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses.
    Xia M; Huang P; Jiang X; Tan M
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33419150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bioengineered pseudovirus nanoparticle displaying SARS-CoV 2 RBD fully protects mice from mortality and weight loss caused by SARS-CoV 2 challenge.
    Xia M; López K; Vago FS; Huang P; Auguste DI; Jiang W; Auguste AJ; Tan M
    Biotechnol J; 2023 Oct; 18(10):e2300130. PubMed ID: 37300425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioengineered Norovirus S
    Xia M; Huang P; Sun C; Han L; Vago FS; Li K; Zhong W; Jiang W; Klassen JS; Jiang X; Tan M
    ACS Nano; 2018 Nov; 12(11):10665-10682. PubMed ID: 30234973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of rotavirus NSP4 protein on the immune response and protection of the S
    Liu C; Huang P; Zhao D; Xia M; Zhong W; Jiang X; Tan M
    Vaccine; 2021 Jan; 39(2):263-271. PubMed ID: 33309483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Live Oral Priming and Intramuscular Boosting Regimen with Rotarix
    Hensley C; Nyblade C; Zhou P; Parreño V; Ramesh A; Frazier A; Frazier M; Garrison S; Fantasia-Davis A; Cai R; Huang PW; Xia M; Tan M; Yuan L
    Vaccines (Basel); 2023 May; 11(5):. PubMed ID: 37243031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice.
    Xia M; Huang P; Jiang X; Tan M
    Vaccine; 2019 Jul; 37(30):4103-4110. PubMed ID: 31201052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudovirus Nanoparticles Displaying
    Xia M; Huang P; Vago F; Jiang W; Tan M
    Vaccines (Basel); 2023 Oct; 11(11):. PubMed ID: 38005982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice.
    Tamminen K; Lappalainen S; Huhti L; Vesikari T; Blazevic V
    PLoS One; 2013; 8(7):e70409. PubMed ID: 23922988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverse Genetics Approach for Developing Rotavirus Vaccine Candidates Carrying VP4 and VP7 Genes Cloned from Clinical Isolates of Human Rotavirus.
    Kanai Y; Onishi M; Kawagishi T; Pannacha P; Nurdin JA; Nouda R; Yamasaki M; Lusiany T; Khamrin P; Okitsu S; Hayakawa S; Ebina H; Ushijima H; Kobayashi T
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33087468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans.
    Nair N; Feng N; Blum LK; Sanyal M; Ding S; Jiang B; Sen A; Morton JM; He XS; Robinson WH; Greenberg HB
    Sci Transl Med; 2017 Jun; 9(395):. PubMed ID: 28637924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses.
    Luo G; Zeng Y; Yang H; Li Y; Yang L; Li C; Song F; Zhang S; Li T; Ge S; Zhang J; Xia N
    iScience; 2022 Oct; 25(10):105099. PubMed ID: 36185383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine.
    Li Y; Xue M; Yu L; Luo G; Yang H; Jia L; Zeng Y; Li T; Ge S; Xia N
    Vaccine; 2018 Apr; 36(16):2086-2092. PubMed ID: 29555220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycan Binding Specificity and Mechanism of Human and Porcine P[6]/P[19] Rotavirus VP8*s.
    Sun X; Li D; Qi J; Chai W; Wang L; Wang L; Peng R; Wang H; Zhang Q; Pang L; Kong X; Wang H; Jin M; Gao GF; Duan Z
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29720519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioengineered pseudovirus nanoparticles displaying the HA1 antigens of influenza viruses for enhanced immunogenicity.
    Xia M; Hoq MR; Huang P; Jiang W; Jiang X; Tan M
    Nano Res; 2022; 15(5):4181-4190. PubMed ID: 35106126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirus.
    Padilla-Noriega L; Fiore L; Rennels MB; Losonsky GA; Mackow ER; Greenberg HB
    J Clin Microbiol; 1992 Jun; 30(6):1392-7. PubMed ID: 1320626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus.
    Heinimäki S; Hankaniemi MM; Sioofy-Khojine AB; Laitinen OH; Hyöty H; Hytönen VP; Vesikari T; Blazevic V
    Vaccine; 2019 Dec; 37(51):7509-7518. PubMed ID: 31585726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus.
    Giammarioli AM; Mackow ER; Fiore L; Greenberg HB; Ruggeri FM
    Virology; 1996 Nov; 225(1):97-110. PubMed ID: 8918537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotavirus VP4 Epitope of a Broadly Neutralizing Human Antibody Defined by Its Structure Bound with an Attenuated-Strain Virion.
    Jenni S; Li Z; Wang Y; Bessey T; Salgado EN; Schmidt AG; Greenberg HB; Jiang B; Harrison SC
    J Virol; 2022 Aug; 96(16):e0062722. PubMed ID: 35924923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.